CAV1 and endometrial cancer: Mechanistic studies showed that WTAP increased the m6A modification of caveolin 1 (CAV-1) mRNA 3′-UTR and downregulated CAV-1 expression, thereby activating the NF-κB signaling pathway in endometrial cancer to maintain the malignant characteristics of tumor cells [121].